112 related articles for article (PubMed ID: 32281263)
1. Benzimidazole Derivatives as Novel Zika Virus Inhibitors.
Hue BTB; Nguyen PH; De TQ; Van Hieu M; Jo E; Van Tuan N; Thoa TT; Anh LD; Son NH; La Duc Thanh D; Dupont-Rouzeyrol M; Grailhe R; Windisch MP
ChemMedChem; 2020 Aug; 15(15):1453-1463. PubMed ID: 32281263
[TBL] [Abstract][Full Text] [Related]
2. Identification of Inhibitors of ZIKV Replication.
Morales Vasquez D; Park JG; Ávila-Pérez G; Nogales A; de la Torre JC; Almazan F; Martinez-Sobrido L
Viruses; 2020 Sep; 12(9):. PubMed ID: 32961956
[TBL] [Abstract][Full Text] [Related]
3. Chloroquine and Sulfadoxine Derivatives Inhibit ZIKV Replication in Cervical Cells.
de Souza AAA; Torres LR; Capobianco LRPL; de Paula VS; Cascabulho CM; Salomão K; Bonecini-Almeida MDG; Ferreira MLG; Boechat N; Pinheiro LCDS; de Souza EM
Viruses; 2020 Dec; 13(1):. PubMed ID: 33383619
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of zika virus infection by fused tricyclic derivatives of 1,2,4,5-tetrahydroimidazo[1,5-a]quinolin-3(3aH)-one.
Xu B; Lee EM; Medina A; Sun X; Wang D; Tang H; Zhou GC
Bioorg Chem; 2020 Nov; 104():104205. PubMed ID: 32916389
[TBL] [Abstract][Full Text] [Related]
5. Development and Validation of a Phenotypic High-Content Imaging Assay for Assessing the Antiviral Activity of Small-Molecule Inhibitors Targeting Zika Virus.
Bernatchez JA; Yang Z; Coste M; Li J; Beck S; Liu Y; Clark AE; Zhu Z; Luna LA; Sohl CD; Purse BW; Li R; Siqueira-Neto JL
Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30061280
[TBL] [Abstract][Full Text] [Related]
6. Antiviral activity of the FDA-approved drug candesartan cilexetil against Zika virus infection.
Loe MWC; Lee RCH; Chu JJH
Antiviral Res; 2019 Dec; 172():104637. PubMed ID: 31669333
[TBL] [Abstract][Full Text] [Related]
7. Non-nucleoside Inhibitors of Zika Virus RNA-Dependent RNA Polymerase.
Gharbi-Ayachi A; Santhanakrishnan S; Wong YH; Chan KWK; Tan ST; Bates RW; Vasudevan SG; El Sahili A; Lescar J
J Virol; 2020 Oct; 94(21):. PubMed ID: 32796069
[TBL] [Abstract][Full Text] [Related]
8. Harringtonine Inhibits Zika Virus Infection through Multiple Mechanisms.
Lai ZZ; Ho YJ; Lu JW
Molecules; 2020 Sep; 25(18):. PubMed ID: 32906689
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of anti-Zika virus activities of broad-spectrum antivirals and NIH clinical collection compounds using a cell-based, high-throughput screen assay.
Adcock RS; Chu YK; Golden JE; Chung DH
Antiviral Res; 2017 Feb; 138():47-56. PubMed ID: 27919709
[TBL] [Abstract][Full Text] [Related]
10. A sensitive virus yield assay for evaluation of Antivirals against Zika Virus.
Goebel S; Snyder B; Sellati T; Saeed M; Ptak R; Murray M; Bostwick R; Rayner J; Koide F; Kalkeri R
J Virol Methods; 2016 Dec; 238():13-20. PubMed ID: 27678028
[TBL] [Abstract][Full Text] [Related]
11. Design, Synthesis and Discovery of N,N'-Carbazoyl-aryl-urea Inhibitors of Zika NS5 Methyltransferase and Virus Replication.
Spizzichino S; Mattedi G; Lauder K; Valle C; Aouadi W; Canard B; Decroly E; Kaptein SJF; Neyts J; Graham C; Sule Z; Barlow DJ; Silvestri R; Castagnolo D
ChemMedChem; 2020 Feb; 15(4):385-390. PubMed ID: 31805205
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and discovery of andrographolide derivatives against Zika virus infection.
Li F; Lee EM; Sun X; Wang D; Tang H; Zhou GC
Eur J Med Chem; 2020 Feb; 187():111925. PubMed ID: 31838328
[TBL] [Abstract][Full Text] [Related]
13. Anti-zika virus activity of polyoxometalates.
Francese R; Civra A; Rittà M; Donalisio M; Argenziano M; Cavalli R; Mougharbel AS; Kortz U; Lembo D
Antiviral Res; 2019 Mar; 163():29-33. PubMed ID: 30653996
[TBL] [Abstract][Full Text] [Related]
14. Identification of novel small-molecule inhibitors of Zika virus infection.
Micewicz ED; Khachatoorian R; French SW; Ruchala P
Bioorg Med Chem Lett; 2018 Feb; 28(3):452-458. PubMed ID: 29258771
[TBL] [Abstract][Full Text] [Related]
15. Structure-activity relationship of flavonoid bifunctional inhibitors against Zika virus infection.
Zou M; Liu H; Li J; Yao X; Chen Y; Ke C; Liu S
Biochem Pharmacol; 2020 Jul; 177():113962. PubMed ID: 32272109
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, and evaluation of novel 4-amino-2-(4-benzylpiperazin-1-yl)methylbenzonitrile compounds as Zika inhibitors.
Wang Y; Zhou R; Quan Y; Chen S; Shi X; Li Y; Cen S
Bioorg Med Chem Lett; 2020 Feb; 30(4):126906. PubMed ID: 31902708
[TBL] [Abstract][Full Text] [Related]
17. Optimization of 1,3-disubstituted urea-based inhibitors of Zika virus infection.
Khachatoorian R; Micewicz ED; Micewicz A; French SW; Ruchala P
Bioorg Med Chem Lett; 2019 Oct; 29(20):126626. PubMed ID: 31477351
[TBL] [Abstract][Full Text] [Related]
18. Human stem cell-derived hepatocyte-like cells support Zika virus replication and provide a relevant model to assess the efficacy of potential antivirals.
Tricot T; Helsen N; Kaptein SJF; Neyts J; Verfaillie CM
PLoS One; 2018; 13(12):e0209097. PubMed ID: 30566505
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and anti-hepatitis B virus activity of a novel class of thiazolylbenzimidazole derivatives.
Luo Y; Yao JP; Yang L; Feng CL; Tang W; Wang GF; Zuo JP; Lu W
Arch Pharm (Weinheim); 2011 Feb; 344(2):78-83. PubMed ID: 21290423
[TBL] [Abstract][Full Text] [Related]
20. N-(2-(arylmethylimino)ethyl)-7-chloroquinolin-4-amine derivatives, synthesized by thermal and ultrasonic means, are endowed with anti-Zika virus activity.
Barbosa-Lima G; da Silveira Pinto LS; Kaiser CR; Wardell JL; De Freitas CS; Vieira YR; Marttorelli A; Cerbino Neto J; Bozza PT; Wardell SMSV; de Souza MVN; Souza TML
Eur J Med Chem; 2017 Feb; 127():434-441. PubMed ID: 28092859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
